{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T19:26:19Z","timestamp":1793042779045,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/j.ahj.2018.04.003","type":"journal-article","created":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T07:47:11Z","timestamp":1523000831000},"page":"27-32","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study"],"prefix":"10.1016","volume":"202","author":[{"given":"Joseph B.","family":"Muhlestein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi T.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oxana","family":"Galenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk U.","family":"Knowlton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Otvos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margery A.","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald L.","family":"Lappe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2018.04.003_bb0005","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1373\/clinchem.2014.232918","article-title":"Glyca: A composite nuclear magnetic resonance biomarker of systemic inflammation","volume":"61","author":"Otvos","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/j.ahj.2018.04.003_bb0010","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12887-016-0688-5","article-title":"Differences in glyca and lipoprotein particle parameters may help distinguish acute kawasaki disease from other febrile illnesses in children","volume":"16","author":"Connelly","year":"2016","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.ahj.2018.04.003_bb0015","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.clinbiochem.2015.05.001","article-title":"Glyca, a biomarker of inflammatory glycoproteins, is more closely related to the leptin\/adiponectin ratio than to glucose tolerance status","volume":"48","author":"Dullaart","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ahj.2018.04.003_bb0020","doi-asserted-by":"crossref","first-page":"375","DOI":"10.2337\/dc16-1569","article-title":"Novel protein glycan-derived markers of systemic inflammation and c-reactive protein in relation to glycemia, insulin resistance, and insulin secretion","volume":"40","author":"Lorenzo","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ahj.2018.04.003_bb0025","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cca.2016.06.012","article-title":"Inflammatory glycoproteins in cardiometabolic disorders, autoimmune diseases and cancer","volume":"459","author":"Connelly","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ahj.2018.04.003_bb0030","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1161\/ATVBAHA.115.305635","article-title":"Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus","volume":"35","author":"Akinkuolie","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.ahj.2018.04.003_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cca.2015.11.001","article-title":"Glyca, a marker of acute phase glycoproteins, and the risk of incident type 2 diabetes mellitus: Prevend study","volume":"452","author":"Connelly","year":"2016","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.ahj.2018.04.003_bb0040","doi-asserted-by":"crossref","first-page":"e001221","DOI":"10.1161\/JAHA.114.001221","article-title":"A novel protein glycan biomarker and future cardiovascular disease events","volume":"3","author":"Akinkuolie","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2018.04.003_bb0045","doi-asserted-by":"crossref","first-page":"e0139057","DOI":"10.1371\/journal.pone.0139057","article-title":"Glyca, a pro-inflammatory glycoprotein biomarker, and incident cardiovascular disease: Relationship with c-reactive protein and renal function","volume":"10","author":"Gruppen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ahj.2018.04.003_bb0050","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1373\/clinchem.2016.255828","article-title":"Comparison of the predictive value of glyca and other biomarkers of inflammation for total death, incident cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events","volume":"62","author":"Duprez","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.ahj.2018.04.003_bb0055","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003822","article-title":"Circulating n-linked glycoprotein side-chain biomarker, rosuvastatin therapy, and incident cardiovascular disease: An analysis from the jupiter trial","volume":"5","author":"Akinkuolie","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ahj.2018.04.003_bb0060","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1373\/clinchem.2016.261636","article-title":"A novel protein glycan-derived inflammation biomarker independently predicts cardiovascular disease and modifies the association of hdl subclasses with mortality","volume":"63","author":"McGarrah","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/j.ahj.2018.04.003_bb0065","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13075-015-0646-x","article-title":"Utility of a novel inflammatory marker, glyca, for assessment of rheumatoid arthritis disease activity and coronary atherosclerosis","volume":"17","author":"Ormseth","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ahj.2018.04.003_bb0070","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13075-016-0982-5","article-title":"A novel inflammatory biomarker, glyca, associates with disease activity in rheumatoid arthritis and cardio-metabolic risk in bmi-matched controls","volume":"18","author":"Bartlett","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.ahj.2018.04.003_bb0075","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1161\/CIRCRESAHA.116.309637","article-title":"Glyca is a novel biomarker of inflammation and subclinical cardiovascular disease in psoriasis","volume":"119","author":"Joshi","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2018.04.003_bb0080","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0002-8703(98)70123-1","article-title":"Implementation of a computerized cardiovascular information system in a private hospital setting","volume":"136","author":"Taylor","year":"1998","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2018.04.003_bb0085","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/j.amjcard.2010.04.040","article-title":"Relation of elevated plasma renin activity at baseline to cardiac events in patients with angiographically proven coronary artery disease","volume":"106","author":"Muhlestein","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2018.04.003_bb0090","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/j.cll.2006.07.006","article-title":"Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy","volume":"26","author":"Jeyarajah","year":"2006","journal-title":"Clin Lab Med"},{"key":"10.1016\/j.ahj.2018.04.003_bb0095","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1089\/met.2014.0050","article-title":"Lipoprotein insulin resistance index: A lipoprotein particle-derived measure of insulin resistance","volume":"12","author":"Shalaurova","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/j.ahj.2018.04.003_bb0100","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.clinbiochem.2016.09.004","article-title":"Utility of high density lipoprotein particle concentration in predicting future major adverse cardiovascular events among patients undergoing angiography","volume":"49","author":"May","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.ahj.2018.04.003_bb0105","series-title":"Systems medicine links microbial inflammatory response with glycoprotein-associated mortality risk","author":"Ritchie","year":"2015"},{"key":"10.1016\/j.ahj.2018.04.003_bb0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1365-2249.1995.tb06659.x","article-title":"The acute phase protein response in patients receiving subcutaneous il-6","volume":"102","author":"Banks","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ahj.2018.04.003_bb0115","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"340","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2018.04.003_bb0120","first-page":"25","article-title":"Acute phase proteins in transplant patients- review","volume":"15","author":"sobiesiak","year":"2003","journal-title":"Transplant Med"},{"key":"10.1016\/j.ahj.2018.04.003_bb0125","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/138920307779941497","article-title":"The acute phase protein alpha1-acid glycoprotein: A model for altered glycosylation during diseases","volume":"8","author":"Ceciliani","year":"2007","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.ahj.2018.04.003_bb0130","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1373\/clinchem.2016.255828","article-title":"Comparison of the predictive value of glyca and other biomarkers of inflammation for total death, incident cardiovascular events, noncardiovascular and noncancer inflammatory-related events, and total cancer events","volume":"62","author":"Duprez","year":"2016","journal-title":"Clin Chem"},{"key":"10.1016\/j.ahj.2018.04.003_bb0135","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.115.308078","article-title":"Circulating n-linked glycoprotein acetyls and longitudinal mortality risk","volume":"118","author":"Lawler","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.ahj.2018.04.003_bb0140","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1111\/j.1524-4733.2009.00602.x","volume":"12","author":"Johnson","year":"2009","journal-title":"Value Health"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318301108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870318301108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T06:00:05Z","timestamp":1757570405000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870318301108"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8]]},"references-count":28,"alternative-id":["S0002870318301108"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2018.04.003","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GlycA and hsCRP are independent and additive predictors of future cardiovascular events among patients undergoing angiography: The intermountain heart collaborative study","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2018.04.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}